These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36736229)

  • 1. Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021.
    Hasin DS; Borodovsky J; Shmulewitz D; Walsh C; Struble CA; Livne O; Habib MI; Fink DS; Aharonovich E; Budney A
    Addict Behav; 2023 May; 140():107617. PubMed ID: 36736229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws.
    Hasin DS; Borodovsky J; Shmulewitz D; Walsh C; Livne O; Struble CA; Aharonovich E; Fink DS; Budney A
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109159. PubMed ID: 34844095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019.
    Hasin DS; Wall MM; Alschuler D; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
    medRxiv; 2023 Jul; ():. PubMed ID: 37503049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17.
    Weinberger AH; Wyka K; Kim JH; Smart R; Mangold M; Schanzer E; Wu M; Goodwin RD
    Addiction; 2022 Jun; 117(6):1768-1777. PubMed ID: 34985165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recreational cannabis legalization and transitions in cannabis use: findings from a nationally representative longitudinal cohort in the United States.
    Gunadi C; Zhu B; Shi Y
    Addiction; 2022 Oct; 117(10):2651-2659. PubMed ID: 35618659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws.
    Martins SS; Segura LE; Levy NS; Mauro PM; Mauro CM; Philbin MM; Hasin DS
    JAMA Netw Open; 2021 Sep; 4(9):e2127002. PubMed ID: 34570205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of marijuana legalization on cannabis-related visits to the emergency department.
    Tolan NV; Terebo T; Chai PR; Erickson TB; Hayes BD; Uljon SN; Petrides AK; Demetriou CA; Melanson SEF
    Clin Toxicol (Phila); 2022 May; 60(5):585-595. PubMed ID: 34935567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.
    Hasin DS; Wall MM; Choi CJ; Alschuler DM; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Sherman S; Saxon AJ
    JAMA Psychiatry; 2023 Apr; 80(4):380-388. PubMed ID: 36857036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.
    Shi Y
    Addiction; 2021 Jul; 116(7):1782-1793. PubMed ID: 33217090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Kilmer B; Hammond D
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):923-932. PubMed ID: 35363550
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
    Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
    Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Twitter-based survey on marijuana concentrate use.
    Daniulaityte R; Zatreh MY; Lamy FR; Nahhas RW; Martins SS; Sheth A; Carlson RG
    Drug Alcohol Depend; 2018 Jun; 187():155-159. PubMed ID: 29669296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates.
    Livne O; Budney A; Borodovsky J; Walsh C; Shmulewitz D; Fink DS; Struble CA; Habib M; Aharonovich E; Hasin DS
    Addict Behav; 2022 Oct; 133():107374. PubMed ID: 35644057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Made from concentrate? A national web survey assessing dab use in the United States.
    Sagar KA; Lambros AM; Dahlgren MK; Smith RT; Gruber SA
    Drug Alcohol Depend; 2018 Sep; 190():133-142. PubMed ID: 30029166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?
    Hall W; Leung J; Carlini BH
    Addiction; 2023 Jun; 118(6):998-1003. PubMed ID: 36662648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping cannabis potency in medical and recreational programs in the United States.
    Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
    PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study.
    Hasin DS; Wall MM; Alschuler DM; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
    Lancet Psychiatry; 2023 Nov; 10(11):877-886. PubMed ID: 37837985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
    Shi Y; Cao Y; Shang C; Pacula RL
    Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019.
    Mauro PM; Gutkind S; Askari MS; Hasin DS; Samples H; Mauro CM; Annunziato EM; Boustead AE; Martins SS
    Drug Alcohol Depend; 2024 Apr; 257():111113. PubMed ID: 38382162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use among adult marijuana and nicotine e-cigarette or vaping product users, 2020.
    Watson CV; Alexander DS; Oliver BE; Trivers KF
    Addict Behav; 2022 Sep; 132():107349. PubMed ID: 35580371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.